Follow this link: Notice of General Meeting
Follow this link: Notice of General Meeting
Read the original post: BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
Link: CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
Read more: Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
Read the original here: Cognition Therapeutics Announces Results of Pre-specified Analysis of SHINE Study Data Presented at CTAD
See original here: Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity
View post: Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
Original post: Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update
See more here: Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
Here is the original post: BioVie Inc. Announces Closing of Registered Direct Offering
Recent Comments